Determining Constituents In Eye Patents (Class 600/318)
-
Patent number: 10646143Abstract: Non-invasive optical detection devices and techniques that use optically discriminative detection of returned probe light from a target by spatially separating the returned probe light from the deep tissue structure and the returned probe light from the skin surface and the shallow tissue structure based on different wave vector components to improve the optical detection sensitivity in detecting the returned probe light from the deep tissue structure with reduced optical interference by the returned probe light form the skin surface and the shallow tissue structure.Type: GrantFiled: March 8, 2013Date of Patent: May 12, 2020Assignee: Alethus, Inc.Inventor: Feiling Wang
-
Patent number: 10349831Abstract: An optical measuring instrument 1 is equipped with an optical system 20 to be used for measuring a characteristic of the aqueous humor in the anterior chamber 13 of an eyeball 10 of a measurement subject person and a holding unit 50 which holds the optical system 20 etc. The optical system 20 is equipped with a light emitting system 20A and a photodetecting system 20B. An optical path 28 is set so that light emitted from the light emitting system 20A passes through (traverses) the anterior chamber 13 and is detected by the photodetecting system 20B in a state that the eyeball 10 is turned outward.Type: GrantFiled: May 6, 2016Date of Patent: July 16, 2019Assignee: FUJI XEROX CO., LTD.Inventors: Kazuyuki Matsushita, Kazutaka Takeda, Kohei Yukawa, Hideaki Ozawa, Taku Kinoshita, Hideo Nakayama
-
Patent number: 9961307Abstract: An eyeglass recorder includes multiple scene cameras for respectively recording frontal scenes along the viewer's horizontal line-of-sight and depending scenes at approximately a 45° angle downwardly from the viewer's horizontal line-of-sight. The viewer's eye movement is concurrently monitored to differentiate between the viewing of the recorded frontal and depending scenes and to detect saccadic eye motion for assessment of the viewer's level of interest in the viewed scenes.Type: GrantFiled: June 29, 2015Date of Patent: May 1, 2018Inventor: Lee S. Weinblatt
-
Patent number: 9924895Abstract: A specialized spectrometer comprises a light source to generate a monochromatic light beam to generate resonance Raman peaks or resonance near infrared absorption peaks from a region of the subject and a reference light source to illuminate the region with a reference light beam. The light energy from the resonance Raman peaks can be measured with a detector coupled to an optical wavelength separator. A portion of the reference beam scattered from the region can be measured with a reference detector. An amount of the constituent can be determined with a processor in response to the resonance Raman peaks measured with the detector and the portion of the reference beam measured with the reference detector. The illumination of the region with reference beam with the monochromatic beam allows accurate determination of the amount of the constituent, and the amount may comprise a concentration, such as an amount per unit volume.Type: GrantFiled: September 20, 2017Date of Patent: March 27, 2018Assignee: LivSpek Medical Technologies Inc.Inventors: Andrew H. Rawicz, Sara Moghaddamjoo, Bruno Jaggi
-
Patent number: 9915829Abstract: The present invention discloses methods and apparatus for methods and apparatus for manufacturing an Ophthalmic Lens with passive event coloration mechanisms, which may not require a power source. In some embodiments, the passive event coloration mechanisms may be combined with Rigid Inserts or Media Inserts, wherein the inserts may provide additional functionalities.Type: GrantFiled: May 21, 2013Date of Patent: March 13, 2018Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Randall B. Pugh, Karson S. Putt, Camille Higham, Sharika Snook
-
Method of diagnosing malaria infection in a patient by surface enhanced resonance raman spectroscopy
Patent number: 9671347Abstract: Present disclosure relates to a method of diagnosing malaria infection in a patient by Surface Enhanced Raman Spectroscopy (SERS). The method includes obtaining a sample from said patient, mixing the sample with a suspension of magnetic nanoparticles, wherein said magnetic nanoparticles adsorb hemozoin present in the sample onto their surface, obtaining the SERS spectra of the sample, and correlating the obtained SERS spectra to the presence or amount of hemozoin in the sample, wherein the presence of hemozoin is indicative of malaria infection.Type: GrantFiled: April 9, 2012Date of Patent: June 6, 2017Assignee: Nanyang Technological UniversityInventors: Quan Liu, Clement Yuen -
Patent number: 9658440Abstract: An optical probe for measuring light signals includes a first optical fiber guiding incoming light, a lens focusing incoming light towards a sample and collecting altered light from the sample, a second optical fiber guiding altered light, a light logging device measuring intensity fluctuations in the incoming light, wherein the light logging device is positioned after the first optical fiber, whereby the light logging device receives a part of the incoming light from the first fiber. The optical probe is normally applied for measuring light signals in vivo, and finds its primary applications within the field of optical spectroscopic measurements, where the light signals measured by the probe are applied in combination with an apparatus wherein light signals are analyzed against its spectral components for instance in Raman, fluorescence, phosphorescence absorption, diffusion and transmission studies.Type: GrantFiled: March 12, 2009Date of Patent: May 23, 2017Assignee: RSP SYSTEMS A/SInventor: Morten Henneberg
-
Patent number: 9610032Abstract: A body-mountable device can include a transparent material and a substrate at least partially embedded in the transparent material. The transparent material can have a mounting surface and a surface opposite the mounting surface. A light source can be disposed on the substrate and configured to emit light through the surface opposite the mounting surface. The light source can be controlled by circuitry disposed on the substrate. The circuitry can be configured to receive modulation instructions and modulate the light emitted by the light source based on the modulation instructions.Type: GrantFiled: August 5, 2014Date of Patent: April 4, 2017Assignee: Verily Life Sciences LLCInventors: Robert Francis Wiser, Brian Otis, Andrew Nelson
-
Patent number: 9492630Abstract: There are disclosed a wearable computing device and a method for a user interface. The wearable computing device includes a drowsiness detection unit configured to detect a user's drowsiness; a controller configured to determine whether a current situation corresponds to a first mode not allowing the user's drowsiness or a second mode allowing the user's drowsiness when the user's drowsiness is detected; and a feedback output unit configured to provide the user with at least one feedback comprising a message of the first mode or the second mode according to the mode determined by the controller, wherein the message of the first mode is to fight off the drowsiness and wherein the message of the second mode is to help the user's sleep.Type: GrantFiled: January 29, 2014Date of Patent: November 15, 2016Assignee: LG Electronics Inc.Inventors: Eunhyung Cho, Sinae Chun, Jongho Kim, Jihwan Kim
-
Patent number: 9423635Abstract: Described herein is an integrated Faraday modulator and Faraday compensator (IFMC) system. Further described are methods of making an IFMC system, methods of customizing an IFMC system for a specific application, and methods of optimizing an IFMC system for a specific application. Further described is a robust 3D Finite Element Model (FEM) for designing and optimizing an IFMC system. Further described are optical instruments comprising an integrated Faraday modulator and Faraday compensator requiring only one optical crystal.Type: GrantFiled: January 31, 2014Date of Patent: August 23, 2016Assignee: The University of ToledoInventors: Brent D. Cameron, Brandon W. Clarke
-
Patent number: 9125609Abstract: A portable terminal device capable of measuring and evaluating mental fatigue, its measuring method, and a server computer is provided. The portable terminal device includes an operation unit; an imaging unit; a display screen or light emitting element; and a recording unit. Environmental data, which represents ambient environmental light, is calculated by capturing at least a reference image, first frequency data measured when the user is healthy is associated with first environmental data at the time of the measurement, and the associated data is stored in the recording unit; and a proportion of decrease of second frequency data measured when the user is not healthy from the first frequency data associated with the first environmental data having the same order of magnitude as that of second environmental data at the time of the measurement is calculated to evaluate the degree of fatigue of the user.Type: GrantFiled: August 27, 2009Date of Patent: September 8, 2015Assignee: NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGYInventors: Nobuyoshi Harada, Sunao Iwaki
-
Patent number: 9055902Abstract: An eye-mountable device includes an electrochemical sensor embedded in a polymeric material configured for mounting to a surface of an eye. The electrochemical sensor includes a working electrode, a reference electrode, and a reagent that selectively reacts with an analyte to generate a sensor measurement related to a concentration of the analyte in a fluid to which the eye-mountable device is exposed. The working electrode can have at least one dimension less than 25 micrometers. The reference electrode can have an area at least five times greater than an area of the working electrode. A portion of the polymeric material can surround the working electrode and the reference electrode such that an electrical current conveyed between the working electrode and the reference electrode is passed through the at least partially surrounding portion of the transparent polymeric material.Type: GrantFiled: September 19, 2013Date of Patent: June 16, 2015Assignee: Google Inc.Inventor: Zenghe Liu
-
Patent number: 9014639Abstract: The present invention provides methods of notifying a user of a smartphone event through use of an energizable ophthalmic lens. In some embodiments, the smartphone may be paired with a specified ophthalmic lens, wherein the pairing may limit wireless communication to communication between the two specified devices. The smartphone may transmit smartphone event data, which may activate an indicator in the ophthalmic lens. In some embodiments, the user may respond to the notification of the smartphone event. The response may trigger an internal action within the ophthalmic lens, or the response may be transmitted to the smartphone, triggering an action in the smartphone. The present invention further describes a method of using an ophthalmic lens with a smartphone event indicator, including methods of pairing an ophthalmic lens with the specified smartphone.Type: GrantFiled: July 11, 2013Date of Patent: April 21, 2015Assignee: Johnson & Johnson Vision Care, Inc.Inventors: Randall Braxton Pugh, Camille A. Higham
-
Publication number: 20150085249Abstract: Utilization of a contact device placed on the eye in order to detect physical and chemical parameters of the body as well as the non-invasive delivery of compounds according to these physical and chemical parameters, with signals being transmitted continuously as electromagnetic waves, radio waves, infrared and the like. One of the parameters to be detected includes non-invasive blood analysis utilizing chemical changes and chemical products that are found in the conjunctiva and in the tear film. A transensor mounted in the contact device laying on the cornea or the surface of the eye is capable of evaluating and measuring physical and chemical parameters in the eye including non-invasive blood analysis. The system utilizes eye lid motion and/or closure of the eye lid to activate a microminiature radio frequency sensitive transensor mounted in the contact device. The signal can be communicated by wires or radio telemetered to an externally placed receiver.Type: ApplicationFiled: November 24, 2014Publication date: March 26, 2015Applicant: GEELUX HOLDING, LTD.Inventor: Marcio Marc ABREU
-
Patent number: 8971978Abstract: Apparatus, systems and methods employing a contact lens having a pulse oximetry sensor to detect information indicative of a blood oxygen content and/or pulse rate of a wearer of the contact lens, are provided. In some aspects, a contact lens includes a substrate that forms at least part of a body of the contact lens and a pulse oximetry sensor located on or within the substrate that detects information associated with at least one of blood oxygen content or a pulse rate of a wearer of the contact lens. The pulse oximetry sensor comprises one or more light emitting diodes that illuminate a blood vessel of at least one of a region of an eye or an eyelid and a detector that receives light reflected from the blood vessel and generates the information.Type: GrantFiled: August 21, 2012Date of Patent: March 3, 2015Assignee: Google Inc.Inventors: Harvey Ho, Babak Amirparviz
-
Publication number: 20150038809Abstract: An eye-mountable device includes an electrochemical sensor embedded in a polymeric material configured for mounting to a surface of an eye. The electrochemical sensor includes a working electrode and a reference electrode that reacts with an analyte to generate a sensor measurement related to a concentration of the analyte in a fluid to which the eye-mountable device is exposed. An example assembly process includes: forming a sacrificial layer on a working substrate; forming a first layer of a bio-compatible material on the sacrificial layer; providing an electronics module on the first layer of the bio-compatible material, forming a second layer of the bio-compatible material to cover the electronics module; and annealing the first and second layers of the bio-compatible material together to form an encapsulated structure having the electronics module fully encapsulated by the bio-compatible material.Type: ApplicationFiled: October 20, 2014Publication date: February 5, 2015Inventors: James Etzkorn, Babak Amirparviz
-
Patent number: 8914089Abstract: Utilization of a contact device placed on the eye in order to detect physical and chemical parameters of the body as well as the non-invasive delivery of compounds according to these physical and chemical parameters, with signals being transmitted continuously as electromagnetic waves, radio waves, infrared and the like. One of the parameters to be detected includes non-invasive blood analysis utilizing chemical changes and chemical products that are found in the conjunctiva and in the tear film. A transensor mounted in the contact device laying on the cornea or the surface of the eye is capable of evaluating and measuring physical and chemical parameters in the eye including non-invasive blood analysis. The system utilizes eye lid motion and/or closure of the eye lid to activate a microminiature radio frequency sensitive transensor mounted in the contact device. The signal can be communicated by wires or radio telemetered to an externally placed receiver.Type: GrantFiled: June 13, 2008Date of Patent: December 16, 2014Assignee: Geelux Holdings, Ltd.Inventor: Marcio Marc Abreu
-
Patent number: 8909311Abstract: Apparatus, systems and methods employing a contact lens having a pulse oximetry sensor to detect information indicative of a blood oxygen content and/or pulse rate of a wearer of the contact lens, are provided. In some aspects, a contact lens includes a substrate that forms at least part of a body of the contact lens and a pulse oximetry sensor located on or within the substrate that detects information associated with at least one of blood oxygen content or a pulse rate of a wearer of the contact lens. The pulse oximetry sensor comprises one or more light emitting diodes that illuminate a blood vessel of at least one of a region of an eye or an eyelid and a detector that receives light reflected from the blood vessel and generates the information.Type: GrantFiled: September 17, 2013Date of Patent: December 9, 2014Assignee: Google Inc.Inventors: Harvey Ho, Babak A. Parviz
-
Patent number: 8905930Abstract: Methods, systems, and software for controlling infusion pressure, such as during a medical procedure, using systemic blood pressure are described. Systemic blood pressure, such as brachial arm blood pressure or radial artery blood pressure, may be used to estimate central retinal artery blood pressure to estimate critical closing pressure. Further, the disclosure relates to controlling infusion pressure to prevent an increase in intraocular pressure above the estimated critical closing pressure when such is not desired, and, when such is desired, using systemic blood pressure and infusion pressure to control an intentional increase in intraocular pressure above the estimated critical closing pressure to stop intraocular bleeding.Type: GrantFiled: May 20, 2011Date of Patent: December 9, 2014Assignee: Alcon Research, Ltd.Inventor: Steven T. Charles
-
Publication number: 20140249392Abstract: Non-invasive optical measurement of glucose and other dissolved substances in human or animal intraocular fluid. A method takes advantage of the fact that the wave dependence of optical activity is fundamentally different from corneal birefringence. The optical activity of substances dissolved in the intraocular fluid, such as glucose, lactate, ascorbic acid or amino acids, is scaled as a first approximation with the reciprocal value of the wavelength square. In contrast, corneal birefringence is scaled with the reciprocal value of the wavelength and therefore behaves considerably different from the optical activity. For the method according to the invention, a physical model is used, which describes the influence on the polarization of measurement radiation by the components of the eye, particularly by the intraocular fluid and the cornea.Type: ApplicationFiled: April 2, 2014Publication date: September 4, 2014Inventor: Peter Westphal
-
Patent number: 8817261Abstract: Laser pulses are applied to surface plasmon resonant articles such as gold nanoparticles within a microscopy sample to generate a four-wave mixing signal that is detected as the output of the microscopy process.Type: GrantFiled: December 15, 2009Date of Patent: August 26, 2014Assignee: University College Cardiff Consultants Ltd.Inventors: Paola Borri, Wolfgang Langbein, Francesco Masia
-
Patent number: 8815178Abstract: The invention relates to a device and method for non-invasive detection of an analyte in a fluid sample. In one embodiment, the device comprises: a collection chamber containing an absorbent hydrogel material; a fluidic channel connected to the collection chamber; a sensing chamber connected to the fluidic channel, wherein the device is comprised of a compressible housing that allows transfer of fluid collected by the collection chamber to be transferred to be extracted and withdrawn to the sensing chamber upon compression of the device, wherein the sensing chamber contains a material that specifically detects the analyte and wherein the sensing chamber is operably linked to a processor containing a potentiostat that allows detection of the analyte using electrochemical sensing.Type: GrantFiled: March 25, 2010Date of Patent: August 26, 2014Assignee: Arizona Board of Regents on Behalf of Arizona State UniversityInventors: Daniel Bishop, Jeffrey La Belle
-
Patent number: 8798699Abstract: Methods, apparatus, and systems for detecting hemozoin and diagnosing malaria infection are disclosed.Type: GrantFiled: July 16, 2012Date of Patent: August 5, 2014Inventors: Roderick A. Hyde, Nathan P. Myhrvold, Clarence T. Tegreene, Lowell L. Wood, Jr.
-
Publication number: 20140194708Abstract: Apparatus, systems and methods employing a contact lens having a pulse oximetry sensor to detect information indicative of a blood oxygen content and/or pulse rate of a wearer of the contact lens, are provided. In some aspects, a contact lens includes a substrate that forms at least part of a body of the contact lens and a pulse oximetry sensor located on or within the substrate that detects information associated with at least one of blood oxygen content or a pulse rate of a wearer of the contact lens. The pulse oximetry sensor comprises one or more light emitting diodes that illuminate a blood vessel of at least one of a region of an eye or an eyelid and a detector that receives light reflected from the blood vessel and generates the information.Type: ApplicationFiled: August 21, 2012Publication date: July 10, 2014Applicant: GOOGLE INC.Inventors: Harvey Ho, Babak Amirparviz
-
Publication number: 20140192311Abstract: Apparatus, systems and methods of contact lenses with power sources are provided. In some aspects, a contact lens can include a substrate; and a circuit. The circuit can include: one or more sensors disposed on or within the substrate; circuitry disposed on at least a portion of the substrate; one or more photovoltaic cells disposed on at least a portion of the substrate; and a hybrid power component that supplies at least one of two or more different types of power to the circuitry, wherein at least one of the two or more different types of power is radio frequency/inductive power. In various aspects, other types of power can be solar and/or microelectromechanical system power. Additionally, in various aspects, photovoltaic cells can be arrayed in different configurations and/or over a significant portion of a viewing surface of the contact lens. In some aspects, the photovoltaic cells can be transparent.Type: ApplicationFiled: July 26, 2012Publication date: July 10, 2014Applicant: GOOGLE INC.Inventors: Nathan Pletcher, Brian Otis
-
Patent number: 8774885Abstract: Utilization of a contact device placed on the eye in order to detect physical and chemical parameters of the body as well as the non-invasive delivery of compounds according to these physical and chemical parameters, with signals being transmitted continuously as electromagnetic waves, radio waves, infrared and the like. One of the parameters to be detected includes non-invasive blood analysis utilizing chemical changes and chemical products that are found in the conjunctiva and in the tear film. A transensor mounted in the contact device laying on the cornea or the surface of the eye is capable of evaluating and measuring physical and chemical parameters in the eye including non-invasive blood analysis. The system utilizes eye lid motion and/or closure of the eye lid to activate a microminiature radio frequency sensitive transensor mounted in the contact device. The signal can be communicated by wires or radio telemetered to an externally placed receiver.Type: GrantFiled: July 8, 2010Date of Patent: July 8, 2014Assignee: Geelux Holdings, Ltd.Inventor: Marcio Marc Abreu
-
Patent number: 8755855Abstract: Non-invasive optical measurement of glucose and other dissolved substances in human or animal intraocular fluid. A method takes advantage of the fact that the wave dependence of optical activity is fundamentally different from corneal birefringence. The optical activity of substances dissolved in the intraocular fluid, such as glucose, lactate, ascorbic acid or amino acids, is scaled as a first approximation with the reciprocal value of the wavelength square. In contrast, corneal birefringence is scaled with the reciprocal value of the wavelength and therefore behaves considerably different from the optical activity. For the method according to the invention, a physical model is used, which describes the influence on the polarization of measurement radiation by the components of the eye, particularly by the intraocular fluid and the cornea.Type: GrantFiled: March 2, 2009Date of Patent: June 17, 2014Assignee: Carl Zeiss AGInventor: Peter Westphal
-
Publication number: 20140163329Abstract: Methods and systems for determining a physiological parameter of a subject through interrogation of an eye of the subject with an optical signal are described. Interrogation is performed unobtrusively. The system includes a gaze attractor for attracting the gaze of the subject to cause an eye of the subject to move into alignment with regard to an interrogation signal source and/or response signal sensor to facilitate detection of a signal from the eye of the subject.Type: ApplicationFiled: December 11, 2012Publication date: June 12, 2014Applicant: Elwha LLCInventors: Allen L. Brown, JR., Douglas C. Burger, Eric Horvitz, Roderick A. Hyde, Edward K.Y. Jung, Eric C. Leuthardt, Jordin T. Kare, Chris Demetrios Karkanias, John L. Manferdelli, Craig J. Mundie, Nathan P. Myhrvold, Barney Pell, Clarence T. Tegreene, Willard H. Wattenburg, Charles Whitmer, Lowell L. Wood, JR., Richard N. Zare
-
Patent number: 8740384Abstract: A method and apparatus for measuring a molecular composition of protein molecules. A fluid containing at least two varieties of protein molecules is irradiated with first and second laser light beams having different wavelengths. The molecular composition of the at least two varieties of protein molecules contained in the fluid is measured on the basis of an autocorrelation function of a scattered light signal from the at least two varieties of protein molecules irradiated with the first and second laser light beams having different wavelengths.Type: GrantFiled: September 22, 2010Date of Patent: June 3, 2014Assignee: Kowa Company Ltd.Inventor: Taisuke Hirono
-
Patent number: 8666465Abstract: A device for measuring an analyte concentration level in a subject. The device includes: a light source configured for illuminating at least a portion of an anterior region of an eye of the subject with incident light having a substantially broad illumination spectrum at an angle substantially tangential to the surface of the eye; an optical collector configured for detecting reflected light from the at least a portion of the anterior region of the eye; an analyzer configured for analyzing the detected reflected light; and a processor configured to determine the analyte concentration level in the subject based on the analyzed reflected light.Type: GrantFiled: January 10, 2013Date of Patent: March 4, 2014Assignee: Chromologic LLCInventor: Naresh Menon
-
Publication number: 20140046151Abstract: A method and system perform physiological monitoring. The system includes a first light source and a plurality of optical waveguide couplers, each of the plurality of optical waveguide couplers being arranged at a different predetermined spatial location on an ocular insert to be placed on an eye. The system also includes a plurality of optical waveguides. Each optical waveguide carries light from a second light source to a respective one of the plurality of optical waveguide couplers and carries a received signal from the respective one of the plurality of optical waveguide couplers. A processor receives the received signal from each of the plurality of optical waveguides and monitors a parameter based on the received signal.Type: ApplicationFiled: August 7, 2012Publication date: February 13, 2014Applicant: INTERNATIONAL BUSINESS MACHINES CORPORATIONInventor: Douglas M. Gill
-
Patent number: 8639306Abstract: An eye-property monitoring system and method for performing the steps of (1) illuminating the eye from at least one light source whose wavelength interacts with internal eye properties in an optically active manner, (2) controlling, to make known and stable, the operating-power/light-output level of the source, (3) by such illuminating, producing light-source eye reflections including (a) multiple internal reflections within the outer structure of the eye, and (b) linked with those internal reflections at least one resulting outbound reflection, (4) monitoring the outbound-reflection to detect therein the reflection level associated with the at least one source, and (5) associating such detected reflection level as an indication of certain eye properties, such as aqueous glucose concentration.Type: GrantFiled: February 4, 2012Date of Patent: January 28, 2014Assignee: Brien Holden Vision Diagnostics, Inc.Inventor: Tom N. Cornsweet
-
Patent number: 8560033Abstract: A sensor for intraocular measurements moveable within at least one of an vitreous humor of an eye, an aqueous humor of an eye and an intraocular replacement medium. The sensor includes a magnetic body susceptible to magnetic fields and at least one sensor film.Type: GrantFiled: May 18, 2009Date of Patent: October 15, 2013Assignee: ETH ZurichInventors: Olgac Ergeneman, Karl Vollmers, Jake J. Abbott, Bradley Nelson
-
Publication number: 20130225951Abstract: A method and system of acquisition and processing of data representing oxygen saturation (OS) value of a tissue of a visual system of a subject, such as the optic nerve head and overlying artery and vein. The data is acquired at pre-determined discrete spectral points, including at least two isosbestic points, as a discrete reflectance spectrum, with the use of a multi-spectral optical imaging system that simultaneously produces a plurality of two-dimensional spectrally-discrete images by segmenting an incoming light front with secondary objectives. The OS value is assessed based on determination of areas bound by an acquired discrete reflectance spectrum and an isosbestic line.Type: ApplicationFiled: April 26, 2011Publication date: August 29, 2013Applicant: EYE02 SCAN LLCInventors: Bahram Khoobehi, Hussein Wafapoor, Alexander M. Eaton, Paul Fournier
-
Publication number: 20130217986Abstract: An exemplary method of predicting an amyloidosis status involves obtaining a profile of drusen in a periphery of a retina of a subject; and using the profile to predict an amyloidosis status. Another exemplary method of predicting an amyloidosis status involves identifying a subject, the amyloidosis status of which is desired; and obtaining a profile of drusen in a periphery of a retina of the subject. Another exemplary method of predicting an amyloidosis status involves analyzing a profile of drusen in a periphery of a retina of a subject to predict an amyloidosis status of the subject. Another exemplary method of predicting an amyloidosis status involves comparing a profile of drusen in a periphery of a retina of a subject to a control; and predicting an amyloidosis status of the subject.Type: ApplicationFiled: February 21, 2013Publication date: August 22, 2013Applicant: UCL BUSINESS PLCInventor: UCL Business plc
-
Publication number: 20130172700Abstract: An method for detection of ?-amyloid in aqueous humor, lens, and retina of eye or the deposit of the combination of ??-crystallin and ?-amyloid in lens is provided. A light is emitted to a testing area in the eye. The light frequency is selected according to an absorption spectrum of the test substance, and the frequency is equal or close to a resonant excitation frequency of one of the electronic molecular energy levels of the substance, so as to excite the substance to generate resonance-enhanced Raman effect or pre-resonance Raman effect to form a detection spectrum. The concentration of the substance could be estimated by a peak intensity of the detection spectrum.Type: ApplicationFiled: March 21, 2012Publication date: July 4, 2013Applicant: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTEInventors: Yung-Sung Lan, Chir-Weei Chang
-
Publication number: 20130149714Abstract: An implantable diagnostic device in accordance with the present disclosure includes a probe assembly that can be implemented in a variety of ways. A few example implementations include: a needle inside which is located a bio-sensor chip (the needle being insertable into a human being); a compact package containing the bio-sensor chip (the compact package configured for placement inside a catheter); or a silicon-based bio-sensor package configured for insertion into a vein.Type: ApplicationFiled: December 6, 2012Publication date: June 13, 2013Applicants: SANOFI AVENTIS, CALIFORNIA INSTITUTE OF TECHNOLOGYInventors: CALIFORNIA INSTITUTE OF TECHNOLOGY, Sanofi Aventis
-
Patent number: 8452361Abstract: An ocular sensor (110) is proposed for verification of at least one analyte in an eye fluid. The ocular sensor (110) is composed of at least one sensor material which is designed to change at least one optical characteristic in the presence of the at least one analyte. Furthermore, the ocular sensor (110) comprises at least one sensor chip which has at least one integrated optical detector (122) for verification of the optical characteristic. A measurement system (166) is also proposed for verification of at least one analyte in an eye fluid, which measurement system (166) comprises an ocular sensor (110) according to the invention as well as an evaluation unit (168) which is designed to interchange information with the sensor chip (118).Type: GrantFiled: January 14, 2008Date of Patent: May 28, 2013Assignee: Eyesense AGInventor: Achim Müller
-
Patent number: 8452362Abstract: A device for measuring a hydration status based on an analyte concentration in a subject. The device includes: a light source configured for illuminating at least a portion of an anterior region of an eye of the subject with incident light having a substantially broad illumination spectrum at an angle substantially tangential to the surface of the eye; an optical collector configured for detecting reflected light from the at least a portion of the anterior region of the eye; an analyzer configured for analyzing the detected reflected light; and a processor configured to determine the analyte concentration level in the subject based on the analyzed reflected light, wherein the processor determines a hydration status of the subject based on the analyte concentration level and reference data.Type: GrantFiled: January 26, 2010Date of Patent: May 28, 2013Assignee: Chromologic LLCInventor: Naresh Menon
-
Publication number: 20130131472Abstract: A device for measuring an analyte concentration level in a subject. The device includes: a light source configured for illuminating at least a portion of an anterior region of an eye of the subject with incident light having a substantially broad illumination spectrum at an angle substantially tangential to the surface of the eye; an optical collector configured for detecting reflected light from the at least a portion of the anterior region of the eye; an analyzer configured for analyzing the detected reflected light; and a processor configured to determine the analyte concentration level in the subject based on the analyzed reflected light.Type: ApplicationFiled: January 10, 2013Publication date: May 23, 2013Applicant: CHROMOLOGIC LLCInventor: Chromologic LLC
-
Patent number: 8433117Abstract: An embodiment of the invention provides a method that captures a diagnostic image of a retina having at least one lesion, wherein the lesion includes a plurality of spots to be treated. Information is received from a user interface, wherein the information includes a duration, intensity, and/or wavelength of treatment for each of the spots. A real-time image of the retina is captured; and, a composite image is created by linking the diagnostic image to the real-time image. At least one updated real-time image of the retina is obtained using eye tracking and/or image stabilization; and, an annotated image is created by modifying the composite image based on the updated real-time image. A localized laser beam is delivered to each of the spots according to the information, the composite image, and the annotated image.Type: GrantFiled: November 21, 2009Date of Patent: April 30, 2013Assignee: The United States of America as represented by the Secretary of the ArmyInventor: Henry Hacker
-
Patent number: 8403862Abstract: A method includes directing toward a portion of a subject's body a first pulse of electromagnetic energy. While the portion is in a functional state due to the first pulse, a second pulse is directed toward the portion. At a second-pulse time, reflected energy due to the second pulse is detected. While the portion is in a functional state due to the first and second pulses, a third pulse is directed toward the portion. At a third-pulse time, energy of the third pulse, reflected from the portion, is detected. In response to detecting the pulses at the second-pulse time and the third-pulse time, a characteristic of the portion is quantified resulting from (a) the functional state due to the first pulse and (b) the functional state due to the first and second pulses. A clinical state of the subject is identified. Other embodiments are described.Type: GrantFiled: December 22, 2008Date of Patent: March 26, 2013Assignee: Yeda Research and Development Co. Ltd.Inventors: Amiram Grinvald, Darin Nelson, Harel Primack
-
Patent number: 8385998Abstract: The present invention provides contact lens with integrated biosensor for the continuous, non-invasive monitoring of physiological glucose by employing biocompatible nanostructure-laden lens materials. These contact lenses can be worn by diabetics who can colorimetrically see changes in their contact lens color or other fluorescence-based properties, giving an indication of tear and blood glucose levels. This invention for the glucose biosensor based on the new disposal contact lens provides a safe, convenient and non-expensive glucose sensing device. The sensing device disclosed herein provides an efficient and noninvasive solution for monitoring blood glucose.Type: GrantFiled: October 26, 2009Date of Patent: February 26, 2013Inventors: Jin Zhang, William Gerald Hodge
-
Patent number: 8385997Abstract: Methods, apparatus, and systems for detecting hemozoin and diagnosing malaria infection are disclosed.Type: GrantFiled: December 11, 2007Date of Patent: February 26, 2013Inventors: Roderick A. Hyde, Nathan P. Myhrvold, Clarence T. Tegreene, Lowell L. Wood, Jr.
-
Patent number: 8380270Abstract: A device for measuring an analyte concentration level in a subject. The device includes: a light source configured for illuminating at least a portion of an anterior region of an eye of the subject with incident light having a substantially broad illumination spectrum at an angle substantially tangential to the surface of the eye; an optical collector configured for detecting reflected light from the at least a portion of the anterior region of the eye; an analyzer configured for analyzing the detected reflected light; and a processor configured to determine the analyte concentration level in the subject based on the analyzed reflected light.Type: GrantFiled: January 26, 2010Date of Patent: February 19, 2013Assignee: Chromologic LLCInventor: Naresh Menon
-
Patent number: 8364218Abstract: A method determines the concentration of a substance in a subject's blood. The method includes measuring an interaction of at least one light beam with a portion of the subject's body. The method further includes calculating a value of an optically-measured parameter indicative of the interaction of the at least one light beam with the substance in the portion of the subject's body. The method further includes measuring values of one or more temperature-indicative parameters corresponding to a temperature of the portion of the subject's body. The method further includes accessing an empirical correlation of the optically-measured parameter and the one or more temperature-indicative parameters to concentrations of the substance in blood. The method further includes obtaining a concentration of the substance in the subject's blood using the empirical correlation. The concentration corresponds to the value of the optically-measured parameter and the values of the one or more temperature-indicative parameters.Type: GrantFiled: February 11, 2008Date of Patent: January 29, 2013Assignee: GlucoVista, Inc.Inventor: Jonathan Gerlitz
-
Patent number: 8364219Abstract: An apparatus and method for measuring a concentration of a substance in an eye using a retro-reflected measurement light beam having a first wavelength at which the substance has a non-zero first absorption coefficient and a retro-reflected reference light beam having a second wavelength at which the substance has a second absorption coefficient which is substantially equal to zero. The apparatus further includes a detector positionable to receive the retro-reflected measurement light beam and the retro-reflected reference light beam. The detector is responsive to light having the first wavelength by generating a measurement signal and responsive to light having the second wavelength by generating a reference signal. The apparatus further includes an electrical circuit coupled to the detector. The electrical circuit is responsive to the measurement signal and the reference signal to measure the concentration of the substance in the eye.Type: GrantFiled: December 2, 2009Date of Patent: January 29, 2013Assignee: Gluco Vista, Inc.Inventor: Jonathan Gerlitz
-
Patent number: 8355136Abstract: Wearable or implantable devices combining microfluidic control of sample and reagent flow and micro-cavity surface plasmon resonance sensors functionalized with surface treatments or coatings capable of specifically binding to target analytes, ligands, or molecules in a bodily fluid are provided. The devices can be used to determine the presence and concentration of target analytes in the bodily fluids and thereby help diagnose, monitor or detect changes in disease conditions.Type: GrantFiled: June 13, 2011Date of Patent: January 15, 2013Assignee: Indiana University Research and Technology CorporationInventors: James A. Glazier, Dragos Amarie
-
Patent number: 8346345Abstract: In one aspect the present invention provides methods for assessing a physiological state of a mammalian retina in vivo, the methods of this aspect of the invention each include the steps of (a) irradiating a portion of a mammalian retina, in vivo, with light having a wavelength in the range of from 600 nm to 1000 nm at an intensity sufficient to stimulate two-photon-induced fluorescence in the retina; and (b) assessing a physiological state of the retina by analyzing the fluorescence.Type: GrantFiled: March 11, 2010Date of Patent: January 1, 2013Assignee: University of WashingtonInventors: Yoshikazu Imanishi, Krzysztof Palczewski, Bryan S. Sires, Eric J. Seibel
-
Publication number: 20120296180Abstract: Methods, apparatus, and systems for detecting hemozoin and diagnosing malaria infection are disclosed.Type: ApplicationFiled: July 16, 2012Publication date: November 22, 2012Inventors: Roderick A. Hyde, Nathan P. Myhrvold, Clarence T. Tegreene, Lowell L. Wood, JR.